<DOC>
	<DOC>NCT00485862</DOC>
	<brief_summary>The purpose of the study is to compare sertraline and atomoxetine/sertraline combination therapy in patients with persistent depressive symptoms.</brief_summary>
	<brief_title>Combination Therapy in Patients With Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Meet DSMIV criteria for major depression with a HAMD17 rating scale score of at least 18 at visit 1 Adult men or women, 18 years of age or older Must be able to swallow capsules Laboratory results must show no clinically significant abnormalities If suicidal ideation is present, the investigator should assess its severity and the potential need for other interventions and determine whether these are compatible with study participation Have a documented history of Bipolar I or II disorder, or of psychosis. Have a history of any seizure disorder (other than febrile seizures) or patients who have taken (or are currently taking) anticonvulsants for seizure control. Have a history of ADHD Have a history of severe allergies to more than 1 class of medications or multiple adverse drug reactions Are currently using alcohol, drugs of abuse, or any prescribed or overthecounter medication in a manner which the investigator considers indicative of abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>